Archimed (Syracuse Subco) acquires 91.35% of Jeisys Medical for KRW 911.6bn
- Deal value
- $629m
- Stake
- 91.35%
- Implied 100%
- $688m
- Revenue
- $99m
- Op. income
- $25m
- Multiples
- EQV/EBIT 27.5xPSR 7.0x
Deal value ÷ stake (structure unconfirmed)
2023 연결 · DART-verified
2023 연결 · DART-verified
On implied equity value
DART 20240314001085
- Target
- Jeisys Medical · Aesthetic medical devices
- Buyer
- Archimed (Syracuse Subco) · FI
- Seller
- Kang Dong-hwan, Lee Myung-hoon and tendering shareholders
- Structure
- —
- Announced
- Jun 10, 2024
- Closed
- Aug 16, 2024
- Stage
- Closed
Target
Jeisys Medical, founded in 2004, makes aesthetic medical devices including the radiofrequency systems Potenza, Density and Linearz; it was a KOSDAQ-listed company with a high overseas sales share and was delisted in November 2024.
Deal rationale
French healthcare PE firm Archimed, via its Korean SPC Syracuse Subco, bought the founder's 23.2% and a director's 3.2% at KRW 13,000 per share and launched a tender offer at the same price. The company stated it would carry out a comprehensive share exchange 'as quickly as possible under applicable law' to delist and become a wholly owned subsidiary; reports say Archimed secured over 90% through two tender offers and delisted the company in November 2024 for management efficiency.
| Revenue | $99m |
| Operating income | $25m |
| EBITDA | — |
| Net income | — |
2023 연결 · DART-verified · 20240314001085
Press coverage
- 서울경제 시그널 (2024-06-09): “총 7244억 원 규모로 지난 7일 주가인 1만760원 보다 약 21% 높은 수준이다.”
- 아시아경제 (2024-06-10): “이는 제이시스메디칼 잠재발행주식총수의 72.0%에 해당한다.”
- 데일리메디 (2024-06-10): “아키메드는 이날부터 오는 7월 22일까지 주당 1만3000원에 제이시스메디칼 보통주 5572만4838주(72.0%)에 대한 공개매수를 진행한다.”
- 스마트투데이 (2024-08-19): “프랑스 사모펀드(PEF) 운용사 아키메드는 최근 제이시스메디칼 2차 공개매수를 통해 총 91.35%의 지분을 확보했다.”
- Korea Economic Daily Global (2024-06-10): “Archimed aims to hold 98.4% of Jeisys through the acquisitions”
- 머니투데이 유니콘팩토리 (2025-03-19): “시러큐스서브코를 통해 제이시스메디칼을 7200억원에 인수했다. … 경영효율화를 위해 지난해 11월 상장 폐지했다.”
This is a data entry summarising filings and press reports. Please check the original sources for the figures.